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Introduction: Biomedical applications of nanoparticles (NPs) as enzyme inhibitors have recently 
come to light. Oxides of metals native to the physiological environment (eg, Fe, Zn, Mg, etc.) 
are of particular interest—especially the functional consequences of their enzyme interaction. 




, zinc oxide (ZnO), magnesium oxide (MgO) and nickel 
oxide (NiO) NPs are compared to copper (Cu) and boron carbide (B
4
C) NPs. The functional 
impact of NP interaction to the model enzyme luciferase is determined by 2-dimensional fluo-
rescence difference spectroscopy (2-D FDS) and 2-dimensional photoluminescence difference 
spectroscopy (2-D PLDS). By 2-D FDS analysis, the change in maximal intensity and in 2-D FDS 






.MgO. The induced 
changes in protein conformation are confirmed by tryptic digests and gel electrophoresis. 
Results: Analysis of possible trypsin cleavage sites suggest that cleavage mostly occurs in the 
range of residues 112–155 and 372–439, giving a major 45 kDa band. By 2-D PLDS, it is found 
that B
4




 NPs yield a unique bimodal 
negative decay rate, −7.67×103 and −3.50×101 relative light units respectively. Cu NPs, in par-
ticular, give a remarkable 271% change in enzyme activity. Molecular dynamics simulations in 
water predicted that the surfaces of metal oxide NPs become capped with metal hydroxide groups 
under physiological conditions, while the surface of B
4
C becomes populated with boronic acid 
or borinic acid groups. These predictions are supported by the experimentally determined zeta 
potential. Thin layer chromatography patterns further support this conception of the NP surfaces, 
where stabilizing interactions were in the order ionic.polar.non-polar for the series tested. 
Conclusion: Overall the results suggest that B
4
C and Cu NP functional dynamics on enzyme 
biochemistry are unique and should be examined further for potential ramifications on other 
model, physiological or disease-relevant enzymes.
Keywords: 2-dimensional fluorescence difference, 2-D FDS, AUC, corrected light intensity 
emitted, emission wavelength, excitation wavelength, wavelength of max intensity, RLU
Introduction
Nanoparticle (NP) interactions with proteins and other molecules within the biological 
milieu have been termed the nano-bio interface. This new field has created great excite-
ment within the biomaterials and engineering community.1–7 Recently, the anticancer 
activity of zinc oxide (ZnO) NPs has been shown by our group and several others and is 
now considered a nanoscale chemotherapeutic.8–10 Furthermore, the antibacterial activity 
of ZnO NPs has recently been linked to its ability to serve as a biomimetic inhibitor of 
the beta-galactosidase enzyme.11 Indeed nickel oxide (NiO), magnesium oxide (MgO) 
and ZnO possess some inherent catalytic activity themselves.12–14 Strikingly, NiO NPs 
have been shown to restore the function of fragmented enzyme that is nonfunctional in 
solution.3 Thus, the biochemical activity of physiological metal oxide NPs including 
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zinc, iron, magnesium and others and their functional impact 
on enzymes are of tremendous interest but have never before 
been directly compared. Furthermore, studies on some NP 
compositions suggest that boron carbide (B
4
C) NPs may dis-
turb RNA–protein interactions and that copper (Cu) NPs may 
strongly influence protein secondary structure, yet the effect of 
these NPs on biochemical activity remains unexplored.15,36
What is known about NP–protein interaction is based pri-
marily on transport proteins or those which are highly preva-
lent in blood such as albumin.7,15–19 In these cases, a variety of 
different techniques were employed to investigate NP–protein 
interaction, including (but not limited to) circular dichroism 
(CD), Raman, far UV and infrared spectroscopy, as well as 
isothermal calorimetry.15–19,20 Fluorescence spectroscopy tends 
to be more quantitative,16 and fluorescence difference spectros-
copy (FDS) has been used to investigate changes in protein 
conformation and adsorption to the surface of derivatized 
silica.21 Interaction of ZnO NPs with fibrinogen, globulins and 
albumin resulted in a marked change in the tryptophan (Trp) 
emission spectra compared to the same proteins in solution or 
in contact with other NPs.17 Luciferase (Luc) is often used as a 
model enzyme whose structure22–26 is such that the fluorescence 
of Trp moieties in the hinge region flanking its active site pro-
vide a sensitive probe of conformational changes.27,28 Two-di-
mensional spectroscopy (performed by independent scanning 
of excitation and emission frequencies) provides an excellent 
quantitative measure with which to compare conformational 
changes induced by various NPs upon their interaction to Luc.
In concert with the effects of NPs on protein conformation, 
interaction of NPs with enzymes has been shown to stabilize, 
activate or inhibit them.11,29–32 In addition to fluorescence, the 
exquisite sensitivity of the bioluminescence produced by Luc 
and its detection by photoluminescence (PL) spectroscopy have 
been widely exploited in biotechnology and more recently in 
nanobiotechnology.3,4,29,35 Bioluminescence resonance energy 
transfer between Luc and NPs may be a potential means of ampli-
fying and increasing signal to noise in biosensor applications.4,33–35 
Mapping the bioluminescence difference spectra in 2-dimen-
sions (excitation and emission) provides an excellent quantita-
tive measure with which activity changes induced by various 
NPs upon their interaction with Luc can be compared. More 
importantly, area under the curve (AUC) analysis of the kinetics 
provides a new way to compare the functional impact of NP.
Materials and methods
Materials
ZnO NPs obtained from Dr G Glaspell (Virginia Common-
wealth University) and NiO NPs obtained from Dr K Ghosh 
(Department of Physics, Missouri State University) were 
synthesized as previously described.10 All NPs used were of 







 and Cu nanopowders were purchased 
from PlasmaChem GmbH (Berlin, Germany). MgO nano-
powder was purchased from Sigma-Aldrich (St. Louis, MI, 
USA). The NPs were washed with double-distilled deionized 
water, 70% ethanol/water and ethanol and stored dry prior to 
use. QuantiLum r-Firefly Luc (Ppy Luc, molecular weight 
[MW] 61 kDa, 14.37 mg/mL) and the Luc Assay System 
were obtained from Promega (Madison, WI, USA) and pre-
pared and stored as described by Käkinen et al.32 They were 
subsequently diluted to a 1 mg/mL (16.4 µM) stock solutions 
in 0.01 mM PBS (pH adjusted to 7.8 with 0.01 N NaOH). 
d-luciferin (high-performance liquid chromatography 
[HPLC], 99% purity, monosodium salt) was purchased from 
Pierce Biotechnology (Waltham, MA, USA) and suspended 
in PBS (0.01 mM, pH 7.8) for a stock solution of 100 µg/mL. 
Trypsin-EDTA (0.05%) was purchased from Life Technolo-
gies (Waltham, MA, USA), and GelCode Blue Safe Protein 
Stain was purchased from Thermo Scientific (Waltham, MA, 
USA). All steady-state fluorescence and bioluminescence 
measurements (2-dimensional FDS [2D-FDS], intrinsic 
fluorescence, PL) were conducted on SpectraMax i3x multi-
mode microplate reader at 25°C (Molecular Devices, (San 
Jose, CA, USA)) equipped with a Xenon flash lamp using 
96-well black polypropylene microplates.
Intrinsic fluorescence measurements
Luc (1.64 µM in 0.01 M PBS, pH 7.8) excitation and emission 
spectra were recorded between 250–310 nm (λ
em
 = 342 nm) 
and 315–450 nm (λ
ex
 = 295 nm), respectively. Excitation and 
emission slit width was fixed at 5 nm. For studying NP altera-
tions in Luc fluorescence, Luc samples were manually titrated 
with successive 10 µL additions of NP solutions (100 µg/mL, 
in double-distilled water [ddH
2
O]) to final NP concentra-
tions of 10–100 µg/mL, with 11 samples in total. Luc–NP 
samples were homogenized and incubated for 30 min prior 
to measurement (25°C). Concentration and inner filter effects 
were corrected by zeroing measurements of Luc with each 
NP to identically prepare Luc-ddH
2
O samples (absent NPs). 
The recorded spectra were corrected and analyzed using 
SigmaPlot v12.3.
Fluorescence measurements of 
d-luciferin ± NPs
To verify that the NP complexation occurred to Luc and not 
d-luciferin (substrate), intrinsic fluorescence of d-luciferin 
was conducted as already described. d-luciferin (prepared as 
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Functional dynamics studies on the enzyme nano-bio interface
NP solutions, at a 1:1 ratio, for a final w/v ratio of 1:1 and 
10:1. Excitation and emission spectra were recorded between 
250–500 nm (λ
em
 = 530 nm) and 450–650 nm (λ
ex
 = 390 nm), 
respectively. Concentration and inner filter effects were cor-
rected as already described.
Data analysis
Luc and d-luciferin fluorescence data spectra were obtained 
from the instrument, and raw baseline measurements were 
corrected by subtracting appropriate buffer background 
fluorescence values using SpectraMax Pro 6.5 software. 
Inner filter effects and instrumental variation were cor-





 = 280 nm and λ
ex
 = 295 nm. This was converted 
into corrected intensity values (I
em
) using the well-known 
Lambert–Beer’s law:
 
I ln (10) I C 1
em ex 280





 is the incident excitation intensity, ε is the molar 
absorption coefficient for Luc (3.92×104 M−1cm−1, 280 nm) 
or d-luciferin (6.29×103 M−1cm−1, 280 nm) and C is the 
concentration of the fluorophore. Fluorescence emission is 
proportional to number of excited states present in solution. 
The standard curve (C
1
) was used to obtain the concentra-
tion of fluorophore present in the sample wells (C
2
) for the 













The Trp emission spectra, including the wavelength 
(max λ
em
) at which fluorescence intensity is maximal (I
max
) 
is highly sensitive to changes in local Trp microenviorment. 
Integrated fluorescence intensity, AUC, computed as the area 
under the curve, is a measure for the relative fluorescence 
quantum yield and indicates changes in the overall protein 
environment.37 For each spectra, Luc fluorescence (λ
ex
 = 
295 nm) was integrated between 300 and 380 nm using the 
Gaussian curve fitting function in SigmaPlot v13.0. Fluores-





 and AUC to give a fractional area spectrum, useful 
for comparing the effects of denaturants on protein stabil-
ity and conformation.38 Accordingly, Luc-NP spectra were 





/AUC.27 This was done for better interpretation of the 
overall photochemical excitation and de-excitation processes 
attributed to Luc possessing dual-Trp residue. Fluorescence 
analysis of d-luciferin was conducted in a similar manner 
with extraction of I
em
 from instrumental F
em
 values; however, 
because the photoexcitation and emission process is attributed 
entirely to each molecule, the functional activation resides on 
the excitation efficiency of d-luciferin, I
em
⋅(AUC)−1.
Two-dimensional fluorescence difference 
spectroscopy
2-D FDS measurements were run according to specifica-
tions outlined previously39 with modifications. Fluores-
cence excitation (λ
ex
, 250–310 nm) and emission (λ
em
, 
280–400 nm) wavelengths of Luc were scanned at 2 nm 





, respectively. The measured value was corrected for 
background fluorescence and the resulting values were 
plotted as fluorescence emission vs excitation sensitivity, 
measured in relative fluorescence units (RFU).
Bioluminescence spectra and kinetic 
measurements of luc with/without NPs
Ppy Luc bioluminescence spectra were conducted as 
detailed by manufacturer’s instructions and described by 
Käkinen et al.32 Luc kinetic and bioluminescence experi-
ments were conducted using 20 µL of 0.05 mg/mL Luc 
(0.82 µM) and 100 µL of reconstituted Luc reagent (LR) 
in 96-well opaque polypropylene microplates. Signal was 
recorded on a SpectraMax i3x multi-mode microplate 
reader equipped with LED capability. Instrument sensitivity 
was standardized using serial dilution of Luc samples 
(50 µM–5×10−9 µM) with 100 µL LR. Initial biolumines-
cence spectra were measured between 450 and 750 nm with 
150 ms integration at pH 7.8 and a temperature of 25°C. 
The estimated mixing time was 15 s. Kinetic measure-
ments were recorded directly after initial bioluminescence 
(t
0
 = 60 s) over 600 s at 21 data points. Bioluminescence 
intensity (relative light units [RLU]) readings were mea-
sured between 450 and 750 nm with 150 ms integration. For 
NP-mediated alterations in Luc bioluminescence and kinet-
ics, the bioluminescence spectra (t
0
 = 15 sec) and kinetic 
readings (t
0
 = 60 sec) were recorded identically (as discussed 
already) with pre-incubated Luc–NP mixtures at a 1:1 w/v 
and 10:1 w/v ratio, respectively. Briefly, for the 1:1 w/v 
Luc–NP mixture, 100 µL Luc (100 µg/mL) was added to 
100 µL of homogenized NP (100 µg/mL) and incubated 
under mild agitation (30 min, 25°C). The 10:1 w/v Luc:NP 
mixtures were prepared identically with a 10-fold dilution 
of the 100 µg/mL NP samples. Final Luc concentration 
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Immediately prior to measurements, 20 µL of either 1:1 w/v or 
10:1 w/v Luc–NP mixtures were added to 100 µL of LR.
Thin layer chromatography (Tlc)
NP solutions with a concentration of 10 mg/mL in water were 















A saturated amino acid solution was prepared by adding amino 
acids – lysine (Lys), glutamine (Glu), arginine (Arg), histidine 
(His), tyrosine (Tyr) and threonine (Thr) – to 1 mL ddH
2
O. 
Spotting solutions of amino acid and NPs were prepared in a 
1:1 ratio by volume. In total, 1 µL of the mixture was applied 
to a 13×19 cm TLC plate. The plate was allowed to dry and 
placed in 10 mL of elution buffer (9:1 ratio of ethanol: acetic 
acid [1 M]). The plate was left for 1 hour to allow the eluent to 
elute up the plate. This plate was dried, sprayed with ninhydrin 
staining solution and placed in a drying oven at 60°C for 10 
minutes. Possible interactions/reactions between the amino 
acids and NPs were determined by comparing R
f
 values.
limited proteolysis with trypsin
To investigate the structural perturbation of Luc in the pres-
ence of NP complexation, limited proteolysis by trypsin was 
accomplished. Briefly, Luc–NP samples were prepared at a 
1:1 w/v ratio (0.5 mg/mL) with a final volume of 10 µL, which 
were homogenized, centrifuged and incubated for 5 min at 
25°C. The Luc–NP samples were incubated with 2 µL trypsin 
(0.05% w/v) for the specified time periods (5 min, 15 min, 
30 min and 60 min). Samples were run on sodium dodecyl 
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) 
(100 V, 2 hours) and visualized using GelCode Blue Safe 
Protein. Gels were imaged with a BioRad Molecular Image 
Gel DocXR+ and analyzed with Image Lab software.
luc–NP binding
To determine the quantity of Luc binding to NPs, 1 mg/mL 
NPs and 0.5 mg/mL Luc were added to a final volume of 30 µL 
and spun down for 1, 2 and 3 hours at 14,000 rpm at 4°C. The 
quantity of protein in the supernatant unbound to the NPs was 
obtained using Nanodrop 8000 spectrophotometer.
examination of the effect of NPs on the 
secondary structure of luc
The secondary structure of untreated Luc and Luc–NP 
mixtures was examined by CD spectroscopy (Chirascan; 
Applied Photophysics Ltd., Leatherhead, UK). Luc solution 
was prepared to a concentration of 200 µg/mL. Cu and B
4
C 
NP solutions were prepared in deionized water with two dif-
ferent concentrations, 200 µg/mL and 20 µg/mL. Luc–NP 
solutions with 1:1 and 10:1 ratios (Luc: NP, w/w) were then 
prepared by mixing equal amounts of Luc and NP solutions. 
Prior to mixing, NP solutions were homogenized with a 
probe sonicator (VCX 130; Sonics & Materials, Inc., New-
town, CT, USA) for 2 min at 50% amplitude. The Luc–NP 
mixtures were incubated under ambient conditions at 200 
rpm for 30 min and examined using CD spectroscopy. The 
final concentration of Luc in every CD sample was 100 µg/
mL, and the volume of each sample was 200 µL. CD in the 
UV range (200–260 nm) was monitored with a 0.1 mm path 
length quartz cell at ambient temperature. The CD spectra 
were recorded with a step size of 1.0 nm, bandwidth 0.5 nm 
and an averaging time of 3.0 s. CD spectra processing and 
background subtractions were performed using Pro-Data 
Viewer software (Applied Photophysics Ltd.). The CD data 
were expressed in terms of molar residue ellipticity, [Ɵ], in 
deg cm2 dmol−1. The distribution of secondary structures was 
estimated from the obtained CD spectra by the Dichroweb 
software package42–44 with the K2D algorithm. A total of six 
samples were measured, and all data were presented as mean 
± standard deviation. Data were compared using a Student’s 
t-test with equal variances. A value of P,0.05 was consid-
ered statistically significant.
MTT assay
3T3 mouse fibroblast cells (American Type Culture Collection 
[ATCC]) were seeded on a 96-well plate with 5,000 cells/well 
and allowed to grow for 24 hours in DMEM with 10% FBS 
and 1% penicillin/streptomycin. After 24 hours, the medium 





, NiO, MgO, B
4
C, ZnO and Cu), all at a concentration of 
200 µg/mL in the same DMEM solution as before. Each treat-
ment was tested on four sample wells. There were also four 
wells with cells that did not receive treatment and four wells 
that did not get any cells. After 24 hours with the treatment, 
the treatment was removed and the wells were rinsed with PBS 
and then a 1:20 mix of MTT: indicator-free DMEM was added 
to each well with 110 µL per well and left to metabolize for 
5 hours in the incubator. After 5 hours, 85 µL of the mixture 
was removed from each well and 75 µL of dimethyl sulfoxide 
was added to each well to solubilize the crystals. The plate 
was then put on an orbital shaker at 37°C at 175 revolutions/
minute. After 15 minutes on the orbital shaker, the plate was 
then read on a Synergy H1 Hybrid Multi-Mode Microplate 
Reader for absorbance at a wavelength of 562 nm.
Results
Transmission electron microscopy confirmed the NP size 
and morphology prior to the binding of Luc, which was 
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Functional dynamics studies on the enzyme nano-bio interface
analysis as shown in Table 1. Furthermore, the same 
techniques were used to characterize the NPs after binding 
with Luc. As expected, interactions between these NPs and 
Luc protein caused an increase in hydrodynamic diameter 
for all NPs (Table 1).
The changes in the NP size and ZP demonstrate 
protein–NP interaction consistent with a prior study with 
ZnO NPs.18 The decrease in polydispersity index for Cu 
and increase in ZP for B
4
C in the presence of Luc suggest a 
fundamental difference in their physicochemical interaction 
and were explored further for their impact on Luc enzyme 
structure-function by 2-D FDS and 2-dimensional photolumi-
nescence difference spectroscopy (2-D PLDS), as described 
further in the following text.
2-D FDS can be used to measure protein–NP interaction;39 
here, it was performed comparatively by plotting the change 
in intensity and AUC for Luc as a function of the NP type 
to which it was exposed (Figure 1).
As shown in Figure 1, a concentration-dependent change 
in the 2-D FDS pattern was observed, where the most overt 
change in both maximal fluorescence intensity (I
max
) and 
AUC was for Cu-NP. The remaining data of the series by 
this criterion are summarized in Table 2.
As summarized in Table 2, B
4
C and Cu NPs caused the 
greatest change in 2-D FDS as reflected in the maximal 
fluorescence intensity, its change (ΔI
max
) and AUC analysis. 
While the fluorescence wavelength was unchanged, I
max
 and 
AUC changes are presumed to be due to Trp residues in the 
flexible hinge region, implying an excellent in situ read out 
of the protein’s conformation.27,28
The dramatic change in AUC fluorescence for Cu and 
B
4
C suggested potential conformational changes induced 
in Luc upon interaction with these NPs. To further examine 
this, limited trypsin digestion was performed followed by 
protein gel electrophoresis analysis. Here, degradation is 
being caused by trypsin proteolysis. The rate of proteolysis 
is expected to increase for an unfolded versus a folded pro-
tein (Figure 2).
As shown in Figure 2A and B, Luc–Cu samples degraded 
faster than Luc–B
4
C or Luc-only controls. These data are 
consistent with the hypothesis that absorption of Luc to Cu 
NPs causes partial unfolding and, thus, greater accessibility 
for cleavage. Similar to controls, B
4
C NPs showed an initial 
band migrating at an apparent MW of approximately 45 kDa. 
Although it was not possible to unambiguously identify the 
Luc fragment corresponding to this band from the electro-
phoresis analysis, the trypsin cleavage positions capable of 
producing such a fragment are limited. Trypsin cleavage 
occurs only at Lys (K) or Arg (R) residues, with the neighbor-
ing environment determining the probability of any particular 
cleavage. Notably, cleavage at a particular site implies that 
this site is accessible to trypsin and not completely occluded 
by contact with the NPs. We applied the Cleavage Prediction 
with Decision Trees algorithm40 to determine the probability 
of cleavages that yield fragments with a mass of 45±4 kDa. 
For the shortest durations shown in Figure 2A and B, it can 
be assumed that most Luc molecules are uncleaved or have 
Table 1 Physical characteristics of NPs before and after binding 
of luc
NP ± Luc Size (nm) Zeta potential (mV) PDI
ZnO¥ 138, 1143 25.3, −15.5 0.16, 0.35
cu 124, 174 13.5, −13.6 0.86, 0.33
B4c
¥ 163, 556 −32.5, −16.2 0.16, 0.4
Fe2O3 256, 1043 24.5, −11.8 0.33, 0.58
MgO 272, 311 17.8, −19.7 0.57, 0.36
NiO 56, 523 48.3, −18.2 0.12, 0.36
Notes: ¥a TeM analysis was previously reported for ZnO and B4c NP, but was 
repeated here to confirm nanoscale particles for all compositions studied prior 
to binding protein.10,36 Dls, PDI and ZP analysis of the NPs before (left value) 
and after introduction of luc (right value). The NP concentration range was 
7.3–24 mM.
Abbreviations: NPs, nanoparticles; luc, luciferase; TeM, transmission electron 
microscopy; PDI, polydispersity index; ZP, zeta potential.
Figure 1 2-D FDs spectrum of luc alone and luc in the presence of cu NPs at 25°c 
in 0.01 M PBs (ph 7.8). The y axis represents Iem/aUc in relative absorbance units 
rFU or the change in ΔImax/aUc (%). The x axis represents emission wavelength 
(315–455 nm) (λex = 295 nm). The data are tabulated in Table 2 for all NPs at 
50 µg/ml NP. The black line represents Iem/aUc (corresponding to the black axis) 
and the orange line represents ΔImax/aUc (%) (corresponding to the orange axis).
Abbreviations: 2-D FDS, 2-dimensional fluorescence difference spectroscopy; 
luc, luciferase; NPs, nanoparticles; aUc, area under the curve; rFU, relative 
fluorescence units.
∆
Table 2 Data comparison on the maximal fluoresence emission, 
intensity and aUc
NP Max λem (nm)(a) ΔImax (%) ΔAUC (%)
ZnO 341 ± 2 67.87 66.55
B4c 340 ± 4 83.98 86.82
cu 338 ± 7 85.34 84.26
Fe2O3 340 ± 2 3.96 7.25
MgO 342 ± 4 −2.00 1.76
NiO 341 ± 2 43.36 45.61
Note: aMean±sD.
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Figure 2 sDs-Page analysis of luc tryptic digests in presence of (A) cu or (B) B4c NP. The arrow denotes the lane corresponding to a mass of 45±4 kDa, assigned based 
on prior gels relative to molecular weight markers and the known molecular weight of luc in the main band above. (C) Possible locations of a single cleavage of luc by trypsin 
resulting in the observed 45±4 kDa fragments. luc (PDB ID: 1lcI) is shown in a secondary-structure representation and cleavage locations are highlighted by spheres. The 
color of the spheres indicates the cleavage probability as predicted by the algorithm,40 with green, yellow and red, respectively, denoting probabilities P.0.85, 0.85#P#0.6 
and P,0.6. (D) cleavage locations that preclude formation of 45±4 kDa fragments (magenta) and those locations that are consistent with the formation of 45±4 kDa 
fragments by one or more cleavage events (yellow).
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Functional dynamics studies on the enzyme nano-bio interface
been cleaved only once. Figure 2C shows the 15 locations of 
Luc where a single cleavage can yield 45±4 kDa fragments, 
occupying just two regions of the protein. The Luc image 
is based on the x-ray-derived structure (Protein Data Bank 
identifier [PDB ID]: 1LCI)23 with atomic coordinates for 
missing residues as estimated by MODELLER software.41 
Based on protected regions of the protein not being cleaved, 
these results seem to imply that either residues 372–439 or 
residues 112–155 remain accessible to trypsin when Luc is 
adsorbed to B
4
C NP. Even when multiple cleavage events are 
taken into account, there remain some limitations on where 
cleavage can occur to form 45±4 kDa fragments, as shown 
in Figure 2D. We hypothesize that cleavage of the relatively 
independent C-terminal domain23 at residue 437 or 439 is a 
major contributor to the band at ~45 kDa.
Next, the impact of protein–NP interaction on Luc enzyme 
activity was investigated by 2-D PLDS. The rapid kinetics of 
the enzyme was monitored 60 seconds after the injection of 
the Luciferin substrate. The decay rate, PL spectra and AUC 
were plotted over the course of approximately one half-life 
(11 minutes or 660 seconds), as shown in Figure 3A and B.
As shown in Figure 3, and consistent with enzyme dena-
turation by Cu NPs, nanobiocatalysis was delayed causing a 
negative decay rate within the rapid timespan of the experi-
ment (60–660 seconds). The AUC increased accordingly. 




 NPs was also negative and unique 
relative to the other NPs. Quite surprisingly, in the presence 
of B
4
C NPs, no PL was catalyzed. These data suggested that 
the impact of nano-bio interaction on enzyme function may 
be more complicated than altering protein conformation. 
These data are summarized in Table 3.
The data in Table 3 when taken comparatively suggest 
some plausible mechanistic insight. In addition to partial 
protein denaturation causing loss of activity (as suggested 
in Figure 2), another potential explanation for the delayed 





 is interaction between the NPs and the d-luciferin 
substrate rather than the protein itself. Given the intrinsic 
fluorescence of the luciferin substrate, its quantum efficiency 
could be obtained by integrating AUC for its excitation and 




















∫   
(3)
where relative quantum yield, φ
f
, and integrated intensity, 
I, were used to quantitatively assess overall changes in the 
energy transfer efficiency (φ
f
) of d-luciferin. These plots were 
recorded at two different NP concentrations (0.1 or 0.01 g/mL). 
As shown in Figure 4, for most NPs, the change in quantum 
Figure 3 effect of NPs on luc kinetics and Pl spectra. (A) Time dependence of luc activity in the presence of Fe2O3 and cu NP. (B) luminescence as a function of 
wavelength for luc control and in the presence of cu, Fe2O3 and B4c NP.
Abbreviations: NPs, nanoparticles; luc, luciferase; Pl, photoluminescence.
Table 3 effect of NPs on luc kinetics and Pl spectra
NP λem (nm)¥ PL decay rate 
(RLU/min)
Δ in activity 
(%)£
ZnO 545 ± 5 9.17×103 45.8
cu 545 ± 5 −7.67×103* 271.0
B4c ND ND ND
Fe2O3 550 ± 5 −3.50×10
1* 31.3
MgO 560 2.67×104 20.4
NiO 545 ± 5 4.33×103 49.1
Notes: luc control λem = 555–562 nm, 3.17×10
4 rlU/min, change in activity 
(0% control). Δ in activity curve compares aUc for activity relative to control. 
¥Values reported as mean ± sD (n = 4). *Negative decay rate (luminescence/time 
$0). £Time period from initial luminescence (t0 = 60 seconds) to final luminescence 
(tf = 660 seconds).
Abbreviations: NPs, nanoparticles; luc, luciferase; Pl, photoluminescence; rlU, 




































































Powered by TCPDF (www.tcpdf.org)
                               1 / 1





yield from the luciferin-only control was negligible (|Δφ
f
|#0.05). 
The exception is Cu NPs, particularly at the 0.1 g/mL 
concentration, for which φ
f
 = 0.76. ZnO NPs also slightly 
impeded d-luciferin photoexcitation, with φ
f
 ≈ 0.9 at the two 
concentrations considered. Altogether, these data suggest that 
for most NPs, conformational changes in the enzyme due to inter-
action with the NPs underlie the changes in enzyme activity.
One major difficulty in understanding the physicochem-
istry of interactions between proteins and NPs is that the 
atomic-scale structure of the NP surfaces in an aqueous 
environment where they encounter enzymes are not well 
characterized. To approximate the chemical structure of the 
NP surfaces, molecular dynamics simulations were used to 
reconstruct ZnO, Cu and B
4
C surfaces in water under ambient 
conditions. As shown in Figure 5A, 79% and 73% of the under-
coordinated Zn and O atoms of the pristine ZnO{1010} surface 
became capped with OH or H groups, respectively. Similarly, 
under-coordinated atoms of the B
4
C surface underwent chemical 
reactions with water to yield boranes and oxygen-containing 
boron moieties. Notably, 96% of surface boron atoms bound 
to carbon formed boronic acid moieties (Figure 5B) or, more 
rarely, borinic acid groups. Surface boron atoms not bound to 
carbon tended to form borane or diborane motifs. The Cu{111} 
surface, on the other hand, underwent much less modification. 
Only 29% of the under-coordinated surface atoms formed 
covalent bonds to water molecules (Figure 5C), leaving a 
majority of the Cu atoms free to make contact with solutes. 
In the experiments, these particles are stabilized by 3% oleic 
acid, which may impact water behavior at the surface.
Another advantage of Luc as a model enzyme is that 
its active site has also been well characterized.46 The key 
Trp moieties making conformational changes in the protein 
induced by NP interaction are measurable by 2-D FDS as 
already mentioned. A model for the substrate binding site 
is shown in Figure S1.25,26 In addition to glutamate and Tyr 
shown in the inset, site-directed mutagenesis and comparative 
homology studies also suggest the importance of His, Thr and 
Lys.28–30,40 Altered chromatographic elution has previously 
been used to gauge interactions to derivatized silica, and 
was used similarly here to investigate NP interaction with 
these different amino acids by TLC (Figure S2). The greatest 
migrational difference (% control R
f
) was seen for Lys that 
occurred to all NPs, likely indicative of ionic interactions. 
However, migration differences were seen for Glu and Thr, 
indicating that hydrogen bonding or polar type interactions 
may also contribute to interaction. Minor migration differ-
ences for Tyr and His do not rule out non-polar stabilizing 
interactions but would need to be extended to other non-polar 
amino acids to better determine their effect.
To confirm conformation changes suggested by the fluo-
rescence, bioluminescence, gel and biochemical activity data 
by Cu and B
4
C NP, a final CD experiment was conducted. 
Figure 6A shows the CD spectra of Luc–Cu mixture with 
1:1 and 10:1, and Figure 6B presents their secondary structure 
distribution. Untreated (native) Luc was used as a control. 
The untreated Luc had two negative ellipticity values at 
208 and 222 nm and contained 39.00% α-helix, 5.67% 
β-sheet and 55.17% random coil structures. The Luc–Cu 
mixtures, on the other hand, showed significant reduction in 
ellipticity values. The α-helix structure of the Luc–Cu mix-
ture with 10:1 ratio was decreased from 39.00% to 25.67%, 
together with an increase of β-sheet from 5.67% to 24.67%. 
Particularly, the α-helix contents of the Luc–Cu mixture 
with 1:1 ratio were significantly decreased as compared with 
untreated Luc (18.23%), along with a substantial increase of 
β-sheet (33.33%). Figure 6C and D displays the CD spectra 
and the secondary structure distribution of Luc–B
4
C mixture 
with two different ratios, respectively. The CD spectra of 
Luc–B
4
C mixture with 10:1 and 1:1 ratio showed remarkably 
lower ellipticity values as compared with untreated Luc, and 
the corresponding secondary structure distribution showed 
a trend similar to that of Luc–Cu mixture. For 1:1 ratio, 
however, B
4
C NPs seemed to induce more conformational 
changes of Luc than Cu NPs. Overall, it was apparent that 
Cu and B
4
C NPs disturbed the secondary structure of Luc, 
and the degree of disturbance increased as the concentration 
of NPs increased.
Figure 4 change in emission–excitation of d-luciferin in the presence or absence 
of NPs. The relative φf (aUc) values are normalized such that the emission and 
excitation aUc values of the d-luciferin samples are 1. NP concentrations are 
indicated in mg/mL (0.1 and 0.01 mg/mL). The dotted line indicates the quadratic fit 
to the aUc data.
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Functional dynamics studies on the enzyme nano-bio interface
Figure 5 reconstruction of pristine nanomaterial surfaces in the presence of water using reactive molecular dynamics simulations. The images on the left show a top-down 
view of the surface after equilibration in vacuum, while the images on the right show the same surfaces after 1 ns of reactive molecular dynamics in contact with water. The 
images on the right are side views of a select portion of the surface, revealing the bonding topology of the chemical modifications. The location of the aqueous phase above 
the surface is indicated. (A) The ZnO{1010} surface becomes almost completely populated by zinc hydroxides. (B) The B4c{1011} surface forms boronic acid groups as well 
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Taken together, the CD data suggest that Cu and B
4
C 
NPs induce substantial structural rearrangement in the Luc 
protein. These data are consistent with the prior fluorescence 
and luminescence measurements. Although the biophysical 
or biochemical impact of the nano-bio interaction was the 
driving force behind this investigation, the NP series were 
tested by MTT assay on NIH3T3 cells. The B
4
C NPs absorb 
in the 562 nm range, interfering with this assay. The cell 





.NiO.ZnO.Cu, where only Cu and to a 





 or controls. Given these data, the NiO and ZnO 
were compared to MgO in the mouse splenocyte assay,45 
where only NiO significantly altered the P1/P2 ratio after 
propidium iodide staining and flow cytometry analysis (data 
not shown).
Conclusion
In conclusion, here comparative functional nano-bio analysis 
was performed. A change in fluorescence intensity was 
observed in the presence of all NPs tested. The largest change 
in both these parameters was seen with Cu NPs and B
4
C NPs. 
These NPs in particular also greatly impact the enzyme kinet-
ics and bioluminescence output of the enzyme, with Cu NPs 
prolonging the kinetics and B
4
C NPs greatly inhibiting biolu-
minescence. Furthermore, trypsin digestion studies show that 
B
4
C NPs protect Luc from degradation, whereas the presence 
of Cu NPs increases the rate of degradation with virtually no 
intact enzyme remaining after only a short period of incuba-
tion. These data suggest that these two NPs in particular have 
very different conformational effects on the enzyme. The 
increase in UV absorbance seen in the presence of Cu NPs, 
as contrasted with all other NPs where sedimentation of the 
Figure 6 (A) cD spectra of luc–cu mixtures with 1:1 and 10:1 ratios. (B) Distribution of secondary structure estimated by the K2D algorithm provided by DichroWeb.42–44 
(C) cD spectra of luc–B4c mixtures with 1:1 and 10:1 ratios. (D) Distribution of the secondary structures. Untreated (native) Luc was used as a control. *Significant 
difference between untreated luc and luc–NP mixtures (n = 6, P,0.05).
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Functional dynamics studies on the enzyme nano-bio interface
Luc bound NPs and loss of UV absorbance in the supernatant 
occurred, is also consistent with partial protein unfolding as 
a consequence of Cu–NP interaction (Figure S3). Certainly 
cerium oxide and ZnO have similarly been shown to induce 
conformational changes on thermal denaturation when 
monitoring Trp fluorescence or UV absorbance changes to 
fibrinogen and albumin similarly.17 By contrast, the fine struc-





and the quantum efficiency energy change in the presence of 
ZnO NPs suggests that the mechanisms of these NP effects on 
enzymes may be more complicated and may involve interac-
tions between the NPs and substrate (in this case, d-luciferin), 
which need to be further explored. Finally, the inhibition seen 
by B
4
C appears to be unique in comparison to the other NPs, 
where no bioluminescence was detected even though this NP 
protects against trypsin digestion and does appear to induce 
conformation change as seen by 2-D FDS and CD. In this case, 
no photoelectron disturbance or quantum efficiency change 
in the presence of substrate was seen. For the most part, the 
metal or metal oxide surfaces appear to behave similarly in 
water where enzyme interaction causes an increase in NP size 
and a decrease in ZP consistent with their protein association. 
However, here again, B
4
C behaves very differently and in 
this case the molecular dynamics simulations of its surface 
shed some insight suggesting that, in water, boron surfaces 
convert to boronic acid, which likely leads to hydrogen-
bonding interactions with protein. This is consistent with 
the ZP change. Whereas the ZP of all other materials shifted 
to the negative upon protein interaction, the ZP of B
4
C NPs 
shifted to the positive. Chromatographic interactions with 







 again suggesting the fundamentally 
different physicochemical behavior of B
4





 metal oxide NPs. These results suggest 
that this panel of NPs, particularly B
4





NP, should be further evaluated against disease-relevant10,18,39 
and physiologically significant enzymes.
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Functional dynamics studies on the enzyme nano-bio interface
Supplementary materials
Figure S2 Tlc migration of amino acids and the change in migration distance relative to the solvent front (rf) in the presence of each NP.
Abbreviations: Tlc, thin layer chromatography; NP, nanoparticle; lys, lysine; glu, glutamate; arg, arginine; his, histidine; Tyr, tyrosine; Thr, threonine.
Figure S1 luc active site showing the luciferin substrate binding site.
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Figure S3 Binding capacity of luc to NP surface. cu NPs cause conformational changes leading to higher OD reading, and subsequently concentration in the supernatant.
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